Log in to save to my catalogue

Safety and efficacy of low-dose liposomal amphotericin B as empirical antifungal therapy for patient...

Safety and efficacy of low-dose liposomal amphotericin B as empirical antifungal therapy for patient...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1492622155

Safety and efficacy of low-dose liposomal amphotericin B as empirical antifungal therapy for patients with prolonged neutropenia

About this item

Full title

Safety and efficacy of low-dose liposomal amphotericin B as empirical antifungal therapy for patients with prolonged neutropenia

Publisher

Tokyo: Springer Japan

Journal title

International journal of clinical oncology, 2013-12, Vol.18 (6), p.983-987

Language

English

Formats

Publication information

Publisher

Tokyo: Springer Japan

More information

Scope and Contents

Contents

Background
Liposomal amphotericin B (L-AmB) is recommended as an empirical antifungal treatment for patients at increased risk of fungal infections although renal toxicity remains a clinical problem. We therefore conducted a pilot study to evaluate the safety and efficacy of low-dose L-AmB as an empirical antifungal therapy for patients with pro...

Alternative Titles

Full title

Safety and efficacy of low-dose liposomal amphotericin B as empirical antifungal therapy for patients with prolonged neutropenia

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1492622155

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1492622155

Other Identifiers

ISSN

1341-9625

E-ISSN

1437-7772

DOI

10.1007/s10147-012-0485-6

How to access this item